- N-[(10-Oxido-9,10-dihydro-9-oxa-10-phosphaphenanthrene)methyl]-1,3,5-triazine-2,4,6-triamine
- N10-(Trifluoroacetyl)pteroic acid
- N-[1,1'-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-2-amine
- N-[1,1'-Biphenyl]-4-yl-9,9-dimethyl-9H-fluoren-3-amine
- N-[1,1'-Biphenyl]-4-yl-N-(4-bromophenyl)-9,9-dimethyl-9H-fluoren-2-amine
- N-[1,1-Bis[(acetyloxy)methyl]-3-(4-octylphenyl)propyl]acetamide
- N'-[(1,1-Dimethylethoxy)carbonyl]-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-N'-methyl-L-lysine
- N1,1-Diphenyl-1,2-ethanediamine
- N-(1,2-Dimethylpropyl)-2-pyridinamine
- 1-(3,4-DIMETHYL-5-ISOXAZOLYL)SULFANIL-AMIDE LITHIUM SALT ">N1-(3,4-DIMETHYL-5-ISOXAZOLYL)SULFANIL-AMIDE LITHIUM SALT
- 1778-09-2Ethanone,1-[4-(methylthio)phenyl]-
- 17781-20-3Acetic acid,(4-chlorophenoxy)-,compd. with 6-amino-2-methyl-2-heptanol (1:1)
- 177834-92-3Eletriptan hydrobromide
- 17783-50-53,8-Diazabicyclo[3.2.1]octane,8-methyl-, hydrochloride (1:2)
- 177839-85-9(R)-3-Amino-4-(4-methylphenyl)butyric acid hydrochloride
- 177842-14-7Benzenemethanamine,4-(difluoromethoxy)-
- 17784-60-04-(1H-Pyrazol-3-yl)pyridine
- 177854-95-41-Propanol,2,2'-dithiobis- (9CI)
- 17786-43-5Tetrabutylphosphonium acetate acetic acid salt
- 17787-40-5Methanaminium,N,N,N-trimethyl-, fluoride, tetrahydrate (9CI)
Hot Products
- 104987-11-3Tacrolimus
- 141-53-7Sodium formate
- 8001-54-5Quaternary ammonium compounds, alkylbenzyldimethyl, chlorides
- 9003-39-8Povidone
- 10161-34-9Trenbolone acetate
- 402957-28-2Telaprevir
- 68-19-9Cyanocobalamin
- 7631-86-9Silicon dioxide
- 302-79-4Tretinoin
- 77-92-9Citric acid
|
Basic Information |
|
Post buying leads |
|
Suppliers |
|
Cas Database |
| Name |
N,N-Dimethylsalicylamide |
EINECS | N/A |
| CAS No. | 1778-08-1 | Density | 1.153g/cm3 |
| PSA | 40.54000 | LogP | 1.09400 |
| Solubility | N/A | Melting Point |
N/A |
| Formula | C9H11 N O2 | Boiling Point | 314.9°Cat760mmHg |
| Molecular Weight | 165.192 | Flash Point | 144.3°C |
| Transport Information | N/A | Appearance | N/A |
| Safety | Moderately toxic by ingestion and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx. | Risk Codes | 22-36 |
| Molecular Structure |
|
Hazard Symbols | Xn |
| Synonyms |
Salicylamide,N,N-dimethyl- (6CI,7CI,8CI); 2-Hydroxy-N,N-dimethylbenzamide;N,N-Dimethyl-2-hydroxybenzamide; N,N-Dimethylsalicylamide; NSC 212254;o-Hydroxy-N,N-dimethylbenzamide |
Article Data | 17 |
N,N-Dimethylsalicylamide Chemical Properties
Product Name: N,N-Dimethylsalicylamide (CAS NO.1778-08-1)
Molecular Formula: C9H11NO2
Molecular Weight: 165.18914g/mol
Mol File: 1778-08-1.mol
Boiling point: 314.9 °C at 760 mmHg
Flash Point: 144.3 °C
Density: 1.153 g/cm3
Surface Tension: 46 dyne/cm
Enthalpy of Vaporization: 57.83 kJ/mol
Vapour Pressure: 0.000244 mmHg at 25°C
XLogP3-AA: 0.4
H-Bond Donor: 1
H-Bond Acceptor: 2
Structure Descriptors of N,N-Dimethylsalicylamide (CAS NO.1778-08-1):
IUPAC Name: 2-hydroxy-N,N-dimethylbenzamide
Canonical SMILES: CN(C)C(=O)C1=CC=CC=C1O
InChI: InChI=1S/C9H11NO2/c1-10(2)9(12)7-5-3-4-6-8(7)11/h3-6,11H,1-2H3
InChIKey: UBAYZMJYXBTDBB-UHFFFAOYSA-N
N,N-Dimethylsalicylamide Toxicity Data With Reference
| Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
|---|---|---|---|---|---|
| mouse | LD50 | intraperitoneal | 1100mg/kg (1100mg/kg) | Yakugaku Zasshi. Journal of Pharmacy. Vol. 86, Pg. 120, 1966. | |
| rat | LD50 | intraperitoneal | 2gm/kg (2000mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 108, Pg. 450, 1953. | |
| rat | LD50 | oral | 2300mg/kg (2300mg/kg) | Journal of Pharmacology and Experimental Therapeutics. Vol. 108, Pg. 450, 1953. |
N,N-Dimethylsalicylamide Safety Profile
Moderately toxic by ingestion and intraperitoneal routes. When heated to decomposition it emits toxic fumes of NOx.
N,N-Dimethylsalicylamide Specification
N,N-Dimethylsalicylamide ,its CAS NO. is 1778-08-1,the synonyms is 4-10-00-00170 (Beilstein Handbook Reference) ; BRN 2361721 ; NSC 212254 ; Salicyldimethylamide ; Benzamide, 2-hydroxy-N,N-dimethyl- (9CI) ; Salicylamide, N,N-dimethyl- .
What can I do for you?
Get Best Price
